The Government of Kenya is currently administering a number of different Covid-19 vaccines countrywide.
Oxford’s Astra Zeneca was the first vaccine to be administered in Kenya, with President Uhuru Kenyatta and a number of government officials having taken their first dose in public.
President Kenyatta recounted that the National Vaccine Deployment Plan had initially aimed to vaccinate 10 million adults by June 2022 and approximately 16 million by June 2023.
He outlined that the strategy had since been revised with a goal of vaccinating 10 million adults by June 2022, and the entire adult population of 26 million Kenyans by 2023.
